Translating advanced photonic sensing toward clinically relevant biomedical applications
Research-driven expertise in photonics and sensing technologies
Our role and focus
BioSense Innovations is focused on the translation of advanced biophotonic and optoacoustic technologies toward clinically relevant biomedical use.
The company operates at the interface of photonics, biomedical engineering, and medical innovation, bridging academic research with clinically relevant application pathways.
BioSense supports the maturation of research-grade technologies toward non-invasive and portable biomedical approaches, with a focus on early disease detection, longitudinal monitoring, and companion diagnostics.
Core Capabilities
BioSense combines deep photonics expertise with translation thinking to support the maturation of advanced biomedical technologies.
Advanced photonic and optoacoustic sensing
Design, integration, and miniaturization strategies of advanced biophotonic and optoacoustic sensing technologies in biomedical applications, enabling depth-resolved and quantitative assessment of clinically relevant tissue features.
Electronics, signal processing, and data analytics
Integration of dedicated electronics, signal acquisition, and data analytics pipelines for multimodal biomedical signals, supporting robust feature extraction and performance benchmarking in relevant environments.
Technology maturation and regulatory readiness
Translation of research-grade technologies toward non-invasive, portable, and scalable biomedical implementations, with early consideration of clinical usability, regulatory context, and exploitation strategy.
Applications
BioSense's translational approach addresses a range of biomedical applications where non-invasive, quantitative sensing and early clinical insight can significantly improve decision-making.